Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis

por Jouenne, Fanélie, Le Goff, Jérôme, Bugnet, Emmanuelle, Salmona, Maud, Meignin, Véronique, Lorillon, Gwenaël, Sadoux, Aurélie, Cherot, Janine, Lebbé, Céleste, Mourah, Samia, Tazi, Abdellatif
Publicado 2020

Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor

por Louveau, Baptiste, Tost, Jörg, Mauger, Florence, Sadoux, Aurélie, Podgorniak, Marie-Pierre, How-Kit, Alexandre, Pages, Cécile, Roux, Jennifer, Da Meda, Laetitia, Lebbe, Céleste, Mourah, Samia
Publicado 2017

Validation of a preclinical model for assessment of drug efficacy in melanoma

por Delyon, Julie, Varna, Mariana, Feugeas, Jean-Paul, Sadoux, Aurélie, Yahiaoui, Saliha, Podgorniak, Marie-Pierre, Leclert, Geoffroy, Dorval, Sarra Mazouz, Dumaz, Nicolas, Janin, Anne, Mourah, Samia, Lebbé, Céleste
Publicado 2016

Correction: Validation of a preclinical model for assessment of drug efficacy in melanoma

por Julie, Delyon, Mariana, Varna, Feugeas, Jean-Paul, Sadoux, Aurélie, Yahiaoui, Saliha, Podgorniak, Marie-Pierre, Leclert, Geoffroy, Dorval, Sarra Mazouz, Dumaz, Nicolas, Janin, Anne, Mourah, Samia, Lebbé, Céleste
Publicado 2016

Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care

por Louveau, Baptiste, Jouenne, Fanelie, Reger de Moura, Coralie, Sadoux, Aurelie, Baroudjian, Barouyr, Delyon, Julie, Herms, Florian, De Masson, Adele, Da Meda, Laetitia, Battistella, Maxime, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Publicado 2019

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma

por Reger de Moura, Coralie, Vercellino, Laetitia, Jouenne, Fanélie, Baroudjian, Barouyr, Sadoux, Aurélie, Louveau, Baptiste, Delyon, Julie, Serror, Kevin, Goldwirt, Lauriane, Merlet, Pascal, Bouquet, Fanny, Battistella, Maxime, Lebbé, Céleste, Mourah, Samia
Publicado 2019

EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF

por Khayati, Farah, Pérez-Cano, Laura, Maouche, Kamel, Sadoux, Aurélie, Boutalbi, Zineb, Podgorniak, Marie-Pierre, Maskos, Uwe, Setterblad, Niclas, Janin, Anne, Calvo, Fabien, Lebbé, Céleste, Menashi, Suzanne, Fernandez-Recio, Juan, Mourah, Samia
Publicado 2015

A novel tumor suppressor function of Kindlin-3 in solid cancer

por Djaafri, Ibtissem, Khayati, Farah, Menashi, Suzanne, Tost, Jorg, Podgorniak, Marie-Pierre, Sadoux, Aurelie, Daunay, Antoine, Teixeira, Luis, Soulier, Jean, Idbaih, Ahmed, Setterblad, Niclas, Fauvel, Françoise, Calvo, Fabien, Janin, Anne, Lebbé, Celeste, Mourah, Samia
Publicado 2014

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

por Louveau, Baptiste, Delyon, Julie, De Moura, Coralie Reger, Battistella, Maxime, Jouenne, Fanelie, Golmard, Lisa, Sadoux, Aurelie, Podgorniak, Marie-Pierre, Chami, Ichrak, Marco, Oren, Caramel, Julie, Dalle, Stephane, Feugeas, Jean-Paul, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Publicado 2019